JPH0442385B2 - - Google Patents
Info
- Publication number
- JPH0442385B2 JPH0442385B2 JP62065527A JP6552787A JPH0442385B2 JP H0442385 B2 JPH0442385 B2 JP H0442385B2 JP 62065527 A JP62065527 A JP 62065527A JP 6552787 A JP6552787 A JP 6552787A JP H0442385 B2 JPH0442385 B2 JP H0442385B2
- Authority
- JP
- Japan
- Prior art keywords
- thienyl
- phenyl
- methyl
- formula
- propanone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 34
- 150000003839 salts Chemical class 0.000 claims abstract description 22
- 239000002253 acid Substances 0.000 claims abstract description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 13
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 11
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 5
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 5
- 239000001257 hydrogen Substances 0.000 claims abstract description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 5
- 239000001301 oxygen Substances 0.000 claims abstract description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 31
- -1 chloro, iodo Chemical group 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 3
- 239000003416 antiarrhythmic agent Substances 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N propiophenone Chemical class CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 claims description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 230000033764 rhythmic process Effects 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 13
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000036279 refractory period Effects 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 210000003540 papillary muscle Anatomy 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 229960001404 quinidine Drugs 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000001746 atrial effect Effects 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- FJYJNRQGQHHGMI-UHFFFAOYSA-N 1-[3-[2-(diethylamino)ethoxy]-4-methylthiophen-2-yl]-3-phenylpropan-1-one Chemical compound CC1=CSC(C(=O)CCC=2C=CC=CC=2)=C1OCCN(CC)CC FJYJNRQGQHHGMI-UHFFFAOYSA-N 0.000 description 2
- CKMRQPQTHYMMPY-UHFFFAOYSA-N 2-chloro-n-ethylethanamine Chemical compound CCNCCCl CKMRQPQTHYMMPY-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000001853 liver microsome Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000000859 sublimation Methods 0.000 description 2
- 230000008022 sublimation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RMGFLMXDCGQKPS-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidine Chemical compound ClCCN1CCCC1 RMGFLMXDCGQKPS-UHFFFAOYSA-N 0.000 description 1
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZAPMTSHEXFEPSD-UHFFFAOYSA-N 4-(2-chloroethyl)morpholine Chemical compound ClCCN1CCOCC1 ZAPMTSHEXFEPSD-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 206010028400 Mutagenic effect Diseases 0.000 description 1
- 238000010934 O-alkylation reaction Methods 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000037024 effective refractory period Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000036747 functional refractory period Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- VIJMMQUAJQEELS-UHFFFAOYSA-N n,n-bis(ethenyl)ethenamine Chemical compound C=CN(C=C)C=C VIJMMQUAJQEELS-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
æ¬çºæã¯äžè¬åŒ
åŒäžããšR1ãšã¯ãæ°ŽçŽ åã¯ã¡ãã«ãæå³ãã
R2ãšR3ãšã¯åäžåã¯ç°ãªã€ãŠããŠãããããã
ãïŒåãŸã§ã®ïŒ£âååãæããã¢ã«ãã«ãã·ã¯ã
ã¢ã«ãã«ãã¢ã«ã±ãã«åã¯ã¢ã«ããã«ã§ãããå
R2ãšR3ãšã¯ãããçµåããŠããçªçŽ ååãšå ±ã«ã
ïŒâïŒåã®ççŽ ååãæãã飜åã®ç°åã¯ãé žçŽ
åã¯çªçŽ ååããããååãšããŠç°äžã«æããŠã
ãŠãã飜åãããç°ã圢æãããã®éãä»å çãª
çªçŽ ã¯ïŒâïŒåã®ççŽ ååãæããã¢ã«ãã«åºã§
眮æãããŠããŠããã§ç€ºãããïŒâïŒâïŒïŒâ
ãžã¢ã«ãã«ã¢ãããšããã·ïŒâïŒâããšãã«ïŒœâïŒ
âããšãã«âïŒâããããã³ã®ãã€ãã¹ã®ã€ã³ã
ããŒãäœçšãæãããæ²»çäžäŸ¡å€ããæ°èŠèªå°äœ
åã³ãããã®é žä»å å¡©ã«é¢ããã æ¬çºæã®ååç©ã¯æ®ã«ãå¿è埪ç°ç³»ã®çŸæ£ã®å Ž
åã«äœ¿çšã§ããã äžèšã®è¬åŠçãªæ§è³ªã®æ ã«ãæ¬çºæã®æ°èŠåå
ç©åã¯ãã®é žä»å å¡©ã¯ãåç¬ãŸãã¯ã®ä»ã®æå¹ç©
質ãšæ··åããŠãéåžžã®å€åã§ïŒã¬ã¿ã«ãåã§ãïŒ
å¿èã®äžæŽèã®é害ã«éããŠãå»è¬ãšããŠäœ¿çšã
ãããšãã§ããã æ¬çºæã¯æŽã«ãäžè¬åŒ åŒäžããšR1ã¯äžèšã®æå³ãæããKat+ã¯ã¢
ã«ã«ãªéå±åã¯ç¬¬ïŒçŽã¢ã³ã¢ããŠã ãæå³ãã
ã§ç€ºãããååç©ãšãåŒ ïŒ»åŒäžãHalã¯ã¯ãã«ããšãŒãåã¯ããã ãæå³
ããR2ãšR3ãšã¯äžèšã®æå³ãæããã§ç€ºãã
ãååç©ãšããåå¿æ§ã«é¢äžããªã溶å€äžã§åå¿
ãããããããŠåŸãããåŒïŒïŒã®å¡©åºããå Žå
ã«ããããã®å¡©ä»å å¡©ã«å€æããããšãç¹åŸŽãšã
ããåŒïŒïŒã®ååç©ã®è£œé æ¹æ³ã«é¢ããã æ¬çºæã®åå¿ã¯ãïŒïŒåŒã®ååç©ã®å¯Ÿå¿ãã
é žãšïŒïŒåŒã®ååç©ãšããäžæŽ»æ§ææ©æº¶å€ãæ®
ã«ãã«ãªãŒã«ããžã¡ãã«ã«ã«ãããŒãããžãšãã«
ã«ã«ãããŒãåã¯ã±ãã³ãäŸãã°ã¡ãã«ãšãã«ã±
ãã³äžã§ãéå°ã®ç¡æ°Žçé žã¢ã«ã«ãªã®ååšäžã§ã
å ç±éæµãããããšã«ãã€ãŠå®æœãããããã
ããé«æ²žç¹å€ã®å Žåã¯ã131âãªã枩床ãè¶ããŠ
ã¯ãªããªããåå¿æéã¯åå¿æéã溶å€æ¬¡ç¬¬ã§æ±º
ãŸãã12ã40æéã®éã§ããããšãã§ããã ïŒïŒåŒã®ååç©ã®å¯Ÿå¿ããé žã¯ãçžå¯Ÿçã«é«
ãé žæ§ãæããŠããã®ã§ãäžèšåå¿æ¡ä»¶äžã§ã¯ã
æ¢ã«çé žã¢ã«ã«ãªã«ããããã®ååç©ã®ã¢ã«ã«ãª
å¡©ãçæããããããŠãã®å¡©ãïŒïŒåŒã®ååç©
ãšãŠã€ãªã¢ã ã¹âãšãŒãã«åæã§åå¿ããããäž
å€æ³ã«ãããšããã®ã¢ã«ã«ã€å¡©ãæ°ŽçŽ åã¢ã«ã«
ãªãæ°Žé žåã¢ã«ã«ãªãã¢ã«ã«ãªã¢ã«ã³ã©ãŒãåã¯
第ïŒçŽé žåã¢ã³ã¢ããŠã ãçšããŠåé¢ããŠè£œé ã
ãããšãå¯èœã§ããããã®ãã®ã次ãã§äžèšæº¶å€
äžã§åŒïŒïŒã®ååç©ãšåå¿ãããããšãå¯èœã§
ããã ïŒïŒåŒã®éé¢å¡©åºã¯ã倧æµãé£çµæ¶æ§ã®æ²¹ã§
ãããããçµæ¶æ§ã®ãããããåçµæ¶ããããšã®
ã§ããé žä»å ååç©ãäŸãã°å¡©åºå¡©ãçµç±ããŠç²Ÿ
補ãè¡ãã®ãããã ç®çååç©ã®é žä»å å¡©ã¯ãèªäœå ¬ç¥ã®æ¹æ³ã«ã
ããäŸãã°ã¢ã«ã«ãªåã¯ã€ãªã³äº€ææš¹èãçšããŠ
éé¢ã®å¡©åºã«å€ãããã®ãã®ãç¡æ©åã¯ææ©ã®
é žãæ®ã«æ²»ççã«å©çšã§ããå¡©ã®çæã«é©åœãªå
å¿ãããããšã«ããããã®ä»ã®å¡©ã«å€ããããšã
ã§ããã æ¬çºæã®ååç©ãšè¬åŠçã«èªããé žä»å å¡©ã圢
æããé žã®äŸã¯ãå¡©é žãèåæ°ŽçŽ é žãããé žãç¡«
é žããã¯ãé žãé ¢é žãé ç³é žãä¹³é žãïœâãã«ãª
ãŒã«ã¹ã«ãã³é žãã¡ã¿ã³ã¹ã«ãã³é žçã§ãããã
ãããªãããä»ã®é žã䜿çšããããšãã§ããã æ¬çºæã®æ°èŠååç©ãšãããã®å¡©ãšã¯å¯æ¥ãªé¢
ä¿ã«ããããããããã¯ããããã«ã€ããŠã®äžèš
ãŸãã¯äžèšã®èšèŒã¯ãã®ãŸãŸä»æ¹ã«ã€ããŠã®èšèŒ
ãšã¿ãŠå·®ãæ¯ãããªããåŒïŒïŒã®åºçºç©è³ªã¯æ
ç®å ¬ç¥ã§ããïŒäŸãã°ATâPS 369739ïŒã ïŒïŒåŒã®ååç©ã¯ãæç®å ¬ç¥ã§ãªããã®ã¯å°
é家ã«å ¬ç¥ã®æ¹æ³ã§ãæç®å ¬ç¥ã®ïŒïŒååç©ã
ããäŸãã°æ¬¡èšã®ããã«ããŠè£œé ã§ããã æ¬çºæã®ååç©ã§åŠçããããšã®ã§ããçæã®
çš®é¡ãšããŠã¯ãã¹ãã©ïŒSupreïŒå¿å®€ã®çæãå¿
宀ã®çæãå¿å®€ã®è±åºåã³ããªãšã³ããªãŒãçæ
ãæããããšãã§ããã æ°èŠååç©ãæäžããã«é©åœãªçšéã¯ãçŽïŒâ
10mgïŒKgïŒæ¥ã§ããããæ²»çãã¹ãæ£è ã®ç¶æ ã«
ãããç«ã®çšéãçšãããããæ°èŠãªååç©ã¯ã
å€ãã®çšéåã³çµå£çã«æäžããããšãã§ããã æåŸã«ãæ¬çºæã¯è¬åŠçã«èªããããæ äœãšäž
ç·ã«ïŒïŒåŒã®ååç©åã¯é žä»å å¡©ã®æå¹éãæ
ããŠããè¬åŠççµæç©ã«é¢ããã ãããæ°èŠååç©ã¯ãæ¬çºæã«ããè¬åŠçãªçµ
æç©äžã§çŽ100ã200mgïŒé ã®å²åã§ååšããããš
ãã§ããããã®éããã®æ®ãã¯èªäœå ¬ç¥ã®è¬å€ç
ã«èªãããå å¡«å€ã§ããã æ¬çºæã®çµæç©ã¯ããããé å€ã®å€ããã€ã«ã
é å€ãã«ãã»ã«ããã€ã¯ãã«ãã»ã«ãæå¹ç©è³ªã
ç·©åŸã«æŸåºããçµæç©åã³ãã®ä»ã®çµå£æäžã«é©
ãã圢ã§ååšããããšãã§ããã 次ã«èšèŒã®å®æœäŸã¯ãæ¬çºæããã詳现ã«èª¬æ
ãããã®ã§ããããããã«ããéå®ããããã®ã§
ã¯ãªãã å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãžã¢ã«ãã«ã¢ãããšããã·ïŒâ
ïŒâããšãã«ïŒœâïŒâããšãã«âïŒâããããã³
âHC1ïŒïŒïŒR1ïŒïŒšãR2ïŒCH3ãR2ïŒR3ïŒãšã
ã«ïŒ ïŒâãžãšãã«ã¢ãããšãã«ã¯ããªãâHC14.9
ïœããã«ãªãŒã«10mlãšæ¿çé žã«ãªãŠã 溶液20mlã®
éã«åé ãããææ©çžãåé¢ããç¡«é žãããªãŠã
ã§ä¹Ÿç¥ãããçŽãã«ãªãŒã«35mläžã®ïŒâïŒïŒâã
ãããã·âïŒâã¡ãã«âïŒâããšãã«ïŒâïŒâã
ãããã³ïŒïœïŒ8.12ïœã¢ã«ïŒã®æº¶æ¶²ã«å ãããã
ã®æ··åç©ãç¡æ°Žã®çé žã«ãªãŠã 3.0ïœãšæ··åãã
22æéå ç±éæµããããå·åŽåŸãæ°Žã§æ¯åºããæ
æ©å±€ãåé¢ããäœåã2nHC1ã§æœåºãããå¡©é ž
çžãäžç·ã«ããçé žãããªãŠã ã§äžåããå¡©ã¡ã
ã¬ã³ã§äœåãæ¯åºãããå¡©åã¡ãã¬ã³å±€ãå䜵
ãã2nHC1ã§æ¯ãšããææ©å±€ãåé¢ã也ç¥ãæ¿
çž®ããããããããŠæ®ã€ãè¡šé¡ååç©ã®HC1å¡©
ããå°éã®ã¢ã»ãã³ã§çµæ¶ãããâ20âã«å·åŽã
åžåŒããŠïŒå掻æ§çãçšããŠã¢ã»ãã³ããåçµæ¶
ãããã åç 1.63ïœïŒ52.6ïŒ ïŒ èç¹ 117â118â å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒ
âããããã³âHC1 (a) ïŒâãšãã«ã¢ããâãšãã«ã¯ããªãã®éé¢21
ã®ãšã¬ã³ãã€ã€ãŒãã©ã¹ã³ã«çé žãžãšãã«800
mlãïŒâãžãšãã«ã¢ããâãšãã«ã¯ããªãâ
HC1 160.0ïœïŒ929.7ïœã¢ã«ïŒã飜åNa2CO3â
溶液100mlåã³Na2CO3120ïœãå ¥ãæ¹æããã
ãã®çé žãžãšãã«å±€ãå液æŒæäžã«åŸæããå
é¢ããNa2SO4ã§ä¹Ÿç¥ãããæ¿ŸéããŠæ»Žå æŒæ
äžã«å ¥ããã (b) âã¢ã«ãã«å ïŒâïŒïŒâããããã·âïŒâã¡ãã«âïŒâã
ãšãã«ïŒâïŒâããšãã«âïŒâããããã³â
28.5ïœïŒ115.7ïœã¢ã«ïŒãçé žãžãšãã«ïŒDECïŒ
280mlã«æº¶ãããIn NaOMe 120mlïŒ120ïœã¢
ã«ïŒã滎å ããå°ããªããžãçµãŠã猶å 枩床90
âã«ãªããŸã§ã¡ãã«ã¢ã«ã³ãŒã«ãæºå»ãããã
ã®åå¿æ··åç©ãçŽ50âã«å·åŽããçé žãžãšãã«
äžã®ïŒâãšãã«ã¢ããâãšãã«ã¯ããªãã®æº¶æ¶²
ã滎å ããã次ãã§åå¿æž©åºŠã40åé90âã«ä¿
æããã (c) éé¢æçµçæç©ã®åŸåŠçæ³ åå¿æ··åç©ãæ¹æããéé žãšãã«åã³
NaHCO3â溶液ãããã500mlã®éã«åé ãã
ãããã®æ°Žçžãéé žãšãã«ïŒÃ200mlã§æ¯ãšã
æœåºããã ãã®ææ©çžãNa2SO4ã§ä¹Ÿç¥ããã·ã€ãŠããš
ã«æŽ»æ§çãšæ¹æããæ¿Ÿéããããã®æº¶æ¶²ãæ¹æ
ããåžåŒæ¿Ÿéãããšããã¯ãè²ã®æ²¹37.5ïœïŒç
è«å€ã®100ïŒ ïŒãããšã«æ®ãã (d) HC1ãžã®å€æ ãã®æ²¹ãCHC13åã³ãšãŒãã«ãããã200ml
äžã«å ¥ãããã®æº¶æ¶²ã湿ã€ãPHâçŽã§é žæ§ã«å
å¿ãããŸã§ïŒ25åïŒä¹Ÿç¥HC1ãå°å ¥ãããã
ã®æº¶æ¶²ãæ¹æããåžåŒæ¿Ÿéããçããæ²¹ãã¢ã»
ãã³50mlããæ¶åºãããïŒæéæ·±å·å·èµåº«äžã«
æŸçœ®ããåžåŒæ¿Ÿéããã¢ã»ãã³ïŒÃ25mlã§æ¶å
ããããã®ç²è£œçæç©ãïŒåãã¢ã»ãã³ããå
çµæ¶ãããïŒæŽ»æ§çãçšããŠïŒã åç23.77ïœïŒ58.27ïŒ ïŒ åŸãããååç©ã¯ãå®æœäŸïŒã«ããåŸãããã
ã®ã«å¯Ÿå¿ããŠããã äžèšæ¹æ³ã«ãããäŸãã°ã次衚ã«èšèŒã®åŒ
ïŒïŒã®ååç©ãåŸãããšãã§ããã
R2ãšR3ãšã¯åäžåã¯ç°ãªã€ãŠããŠãããããã
ãïŒåãŸã§ã®ïŒ£âååãæããã¢ã«ãã«ãã·ã¯ã
ã¢ã«ãã«ãã¢ã«ã±ãã«åã¯ã¢ã«ããã«ã§ãããå
R2ãšR3ãšã¯ãããçµåããŠããçªçŽ ååãšå ±ã«ã
ïŒâïŒåã®ççŽ ååãæãã飜åã®ç°åã¯ãé žçŽ
åã¯çªçŽ ååããããååãšããŠç°äžã«æããŠã
ãŠãã飜åãããç°ã圢æãããã®éãä»å çãª
çªçŽ ã¯ïŒâïŒåã®ççŽ ååãæããã¢ã«ãã«åºã§
眮æãããŠããŠããã§ç€ºãããïŒâïŒâïŒïŒâ
ãžã¢ã«ãã«ã¢ãããšããã·ïŒâïŒâããšãã«ïŒœâïŒ
âããšãã«âïŒâããããã³ã®ãã€ãã¹ã®ã€ã³ã
ããŒãäœçšãæãããæ²»çäžäŸ¡å€ããæ°èŠèªå°äœ
åã³ãããã®é žä»å å¡©ã«é¢ããã æ¬çºæã®ååç©ã¯æ®ã«ãå¿è埪ç°ç³»ã®çŸæ£ã®å Ž
åã«äœ¿çšã§ããã äžèšã®è¬åŠçãªæ§è³ªã®æ ã«ãæ¬çºæã®æ°èŠåå
ç©åã¯ãã®é žä»å å¡©ã¯ãåç¬ãŸãã¯ã®ä»ã®æå¹ç©
質ãšæ··åããŠãéåžžã®å€åã§ïŒã¬ã¿ã«ãåã§ãïŒ
å¿èã®äžæŽèã®é害ã«éããŠãå»è¬ãšããŠäœ¿çšã
ãããšãã§ããã æ¬çºæã¯æŽã«ãäžè¬åŒ åŒäžããšR1ã¯äžèšã®æå³ãæããKat+ã¯ã¢
ã«ã«ãªéå±åã¯ç¬¬ïŒçŽã¢ã³ã¢ããŠã ãæå³ãã
ã§ç€ºãããååç©ãšãåŒ ïŒ»åŒäžãHalã¯ã¯ãã«ããšãŒãåã¯ããã ãæå³
ããR2ãšR3ãšã¯äžèšã®æå³ãæããã§ç€ºãã
ãååç©ãšããåå¿æ§ã«é¢äžããªã溶å€äžã§åå¿
ãããããããŠåŸãããåŒïŒïŒã®å¡©åºããå Žå
ã«ããããã®å¡©ä»å å¡©ã«å€æããããšãç¹åŸŽãšã
ããåŒïŒïŒã®ååç©ã®è£œé æ¹æ³ã«é¢ããã æ¬çºæã®åå¿ã¯ãïŒïŒåŒã®ååç©ã®å¯Ÿå¿ãã
é žãšïŒïŒåŒã®ååç©ãšããäžæŽ»æ§ææ©æº¶å€ãæ®
ã«ãã«ãªãŒã«ããžã¡ãã«ã«ã«ãããŒãããžãšãã«
ã«ã«ãããŒãåã¯ã±ãã³ãäŸãã°ã¡ãã«ãšãã«ã±
ãã³äžã§ãéå°ã®ç¡æ°Žçé žã¢ã«ã«ãªã®ååšäžã§ã
å ç±éæµãããããšã«ãã€ãŠå®æœãããããã
ããé«æ²žç¹å€ã®å Žåã¯ã131âãªã枩床ãè¶ããŠ
ã¯ãªããªããåå¿æéã¯åå¿æéã溶å€æ¬¡ç¬¬ã§æ±º
ãŸãã12ã40æéã®éã§ããããšãã§ããã ïŒïŒåŒã®ååç©ã®å¯Ÿå¿ããé žã¯ãçžå¯Ÿçã«é«
ãé žæ§ãæããŠããã®ã§ãäžèšåå¿æ¡ä»¶äžã§ã¯ã
æ¢ã«çé žã¢ã«ã«ãªã«ããããã®ååç©ã®ã¢ã«ã«ãª
å¡©ãçæããããããŠãã®å¡©ãïŒïŒåŒã®ååç©
ãšãŠã€ãªã¢ã ã¹âãšãŒãã«åæã§åå¿ããããäž
å€æ³ã«ãããšããã®ã¢ã«ã«ã€å¡©ãæ°ŽçŽ åã¢ã«ã«
ãªãæ°Žé žåã¢ã«ã«ãªãã¢ã«ã«ãªã¢ã«ã³ã©ãŒãåã¯
第ïŒçŽé žåã¢ã³ã¢ããŠã ãçšããŠåé¢ããŠè£œé ã
ãããšãå¯èœã§ããããã®ãã®ã次ãã§äžèšæº¶å€
äžã§åŒïŒïŒã®ååç©ãšåå¿ãããããšãå¯èœã§
ããã ïŒïŒåŒã®éé¢å¡©åºã¯ã倧æµãé£çµæ¶æ§ã®æ²¹ã§
ãããããçµæ¶æ§ã®ãããããåçµæ¶ããããšã®
ã§ããé žä»å ååç©ãäŸãã°å¡©åºå¡©ãçµç±ããŠç²Ÿ
補ãè¡ãã®ãããã ç®çååç©ã®é žä»å å¡©ã¯ãèªäœå ¬ç¥ã®æ¹æ³ã«ã
ããäŸãã°ã¢ã«ã«ãªåã¯ã€ãªã³äº€ææš¹èãçšããŠ
éé¢ã®å¡©åºã«å€ãããã®ãã®ãç¡æ©åã¯ææ©ã®
é žãæ®ã«æ²»ççã«å©çšã§ããå¡©ã®çæã«é©åœãªå
å¿ãããããšã«ããããã®ä»ã®å¡©ã«å€ããããšã
ã§ããã æ¬çºæã®ååç©ãšè¬åŠçã«èªããé žä»å å¡©ã圢
æããé žã®äŸã¯ãå¡©é žãèåæ°ŽçŽ é žãããé žãç¡«
é žããã¯ãé žãé ¢é žãé ç³é žãä¹³é žãïœâãã«ãª
ãŒã«ã¹ã«ãã³é žãã¡ã¿ã³ã¹ã«ãã³é žçã§ãããã
ãããªãããä»ã®é žã䜿çšããããšãã§ããã æ¬çºæã®æ°èŠååç©ãšãããã®å¡©ãšã¯å¯æ¥ãªé¢
ä¿ã«ããããããããã¯ããããã«ã€ããŠã®äžèš
ãŸãã¯äžèšã®èšèŒã¯ãã®ãŸãŸä»æ¹ã«ã€ããŠã®èšèŒ
ãšã¿ãŠå·®ãæ¯ãããªããåŒïŒïŒã®åºçºç©è³ªã¯æ
ç®å ¬ç¥ã§ããïŒäŸãã°ATâPS 369739ïŒã ïŒïŒåŒã®ååç©ã¯ãæç®å ¬ç¥ã§ãªããã®ã¯å°
é家ã«å ¬ç¥ã®æ¹æ³ã§ãæç®å ¬ç¥ã®ïŒïŒååç©ã
ããäŸãã°æ¬¡èšã®ããã«ããŠè£œé ã§ããã æ¬çºæã®ååç©ã§åŠçããããšã®ã§ããçæã®
çš®é¡ãšããŠã¯ãã¹ãã©ïŒSupreïŒå¿å®€ã®çæãå¿
宀ã®çæãå¿å®€ã®è±åºåã³ããªãšã³ããªãŒãçæ
ãæããããšãã§ããã æ°èŠååç©ãæäžããã«é©åœãªçšéã¯ãçŽïŒâ
10mgïŒKgïŒæ¥ã§ããããæ²»çãã¹ãæ£è ã®ç¶æ ã«
ãããç«ã®çšéãçšãããããæ°èŠãªååç©ã¯ã
å€ãã®çšéåã³çµå£çã«æäžããããšãã§ããã æåŸã«ãæ¬çºæã¯è¬åŠçã«èªããããæ äœãšäž
ç·ã«ïŒïŒåŒã®ååç©åã¯é žä»å å¡©ã®æå¹éãæ
ããŠããè¬åŠççµæç©ã«é¢ããã ãããæ°èŠååç©ã¯ãæ¬çºæã«ããè¬åŠçãªçµ
æç©äžã§çŽ100ã200mgïŒé ã®å²åã§ååšããããš
ãã§ããããã®éããã®æ®ãã¯èªäœå ¬ç¥ã®è¬å€ç
ã«èªãããå å¡«å€ã§ããã æ¬çºæã®çµæç©ã¯ããããé å€ã®å€ããã€ã«ã
é å€ãã«ãã»ã«ããã€ã¯ãã«ãã»ã«ãæå¹ç©è³ªã
ç·©åŸã«æŸåºããçµæç©åã³ãã®ä»ã®çµå£æäžã«é©
ãã圢ã§ååšããããšãã§ããã 次ã«èšèŒã®å®æœäŸã¯ãæ¬çºæããã詳现ã«èª¬æ
ãããã®ã§ããããããã«ããéå®ããããã®ã§
ã¯ãªãã å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãžã¢ã«ãã«ã¢ãããšããã·ïŒâ
ïŒâããšãã«ïŒœâïŒâããšãã«âïŒâããããã³
âHC1ïŒïŒïŒR1ïŒïŒšãR2ïŒCH3ãR2ïŒR3ïŒãšã
ã«ïŒ ïŒâãžãšãã«ã¢ãããšãã«ã¯ããªãâHC14.9
ïœããã«ãªãŒã«10mlãšæ¿çé žã«ãªãŠã 溶液20mlã®
éã«åé ãããææ©çžãåé¢ããç¡«é žãããªãŠã
ã§ä¹Ÿç¥ãããçŽãã«ãªãŒã«35mläžã®ïŒâïŒïŒâã
ãããã·âïŒâã¡ãã«âïŒâããšãã«ïŒâïŒâã
ãããã³ïŒïœïŒ8.12ïœã¢ã«ïŒã®æº¶æ¶²ã«å ãããã
ã®æ··åç©ãç¡æ°Žã®çé žã«ãªãŠã 3.0ïœãšæ··åãã
22æéå ç±éæµããããå·åŽåŸãæ°Žã§æ¯åºããæ
æ©å±€ãåé¢ããäœåã2nHC1ã§æœåºãããå¡©é ž
çžãäžç·ã«ããçé žãããªãŠã ã§äžåããå¡©ã¡ã
ã¬ã³ã§äœåãæ¯åºãããå¡©åã¡ãã¬ã³å±€ãå䜵
ãã2nHC1ã§æ¯ãšããææ©å±€ãåé¢ã也ç¥ãæ¿
çž®ããããããããŠæ®ã€ãè¡šé¡ååç©ã®HC1å¡©
ããå°éã®ã¢ã»ãã³ã§çµæ¶ãããâ20âã«å·åŽã
åžåŒããŠïŒå掻æ§çãçšããŠã¢ã»ãã³ããåçµæ¶
ãããã åç 1.63ïœïŒ52.6ïŒ ïŒ èç¹ 117â118â å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒ
âããããã³âHC1 (a) ïŒâãšãã«ã¢ããâãšãã«ã¯ããªãã®éé¢21
ã®ãšã¬ã³ãã€ã€ãŒãã©ã¹ã³ã«çé žãžãšãã«800
mlãïŒâãžãšãã«ã¢ããâãšãã«ã¯ããªãâ
HC1 160.0ïœïŒ929.7ïœã¢ã«ïŒã飜åNa2CO3â
溶液100mlåã³Na2CO3120ïœãå ¥ãæ¹æããã
ãã®çé žãžãšãã«å±€ãå液æŒæäžã«åŸæããå
é¢ããNa2SO4ã§ä¹Ÿç¥ãããæ¿ŸéããŠæ»Žå æŒæ
äžã«å ¥ããã (b) âã¢ã«ãã«å ïŒâïŒïŒâããããã·âïŒâã¡ãã«âïŒâã
ãšãã«ïŒâïŒâããšãã«âïŒâããããã³â
28.5ïœïŒ115.7ïœã¢ã«ïŒãçé žãžãšãã«ïŒDECïŒ
280mlã«æº¶ãããIn NaOMe 120mlïŒ120ïœã¢
ã«ïŒã滎å ããå°ããªããžãçµãŠã猶å 枩床90
âã«ãªããŸã§ã¡ãã«ã¢ã«ã³ãŒã«ãæºå»ãããã
ã®åå¿æ··åç©ãçŽ50âã«å·åŽããçé žãžãšãã«
äžã®ïŒâãšãã«ã¢ããâãšãã«ã¯ããªãã®æº¶æ¶²
ã滎å ããã次ãã§åå¿æž©åºŠã40åé90âã«ä¿
æããã (c) éé¢æçµçæç©ã®åŸåŠçæ³ åå¿æ··åç©ãæ¹æããéé žãšãã«åã³
NaHCO3â溶液ãããã500mlã®éã«åé ãã
ãããã®æ°Žçžãéé žãšãã«ïŒÃ200mlã§æ¯ãšã
æœåºããã ãã®ææ©çžãNa2SO4ã§ä¹Ÿç¥ããã·ã€ãŠããš
ã«æŽ»æ§çãšæ¹æããæ¿Ÿéããããã®æº¶æ¶²ãæ¹æ
ããåžåŒæ¿Ÿéãããšããã¯ãè²ã®æ²¹37.5ïœïŒç
è«å€ã®100ïŒ ïŒãããšã«æ®ãã (d) HC1ãžã®å€æ ãã®æ²¹ãCHC13åã³ãšãŒãã«ãããã200ml
äžã«å ¥ãããã®æº¶æ¶²ã湿ã€ãPHâçŽã§é žæ§ã«å
å¿ãããŸã§ïŒ25åïŒä¹Ÿç¥HC1ãå°å ¥ãããã
ã®æº¶æ¶²ãæ¹æããåžåŒæ¿Ÿéããçããæ²¹ãã¢ã»
ãã³50mlããæ¶åºãããïŒæéæ·±å·å·èµåº«äžã«
æŸçœ®ããåžåŒæ¿Ÿéããã¢ã»ãã³ïŒÃ25mlã§æ¶å
ããããã®ç²è£œçæç©ãïŒåãã¢ã»ãã³ããå
çµæ¶ãããïŒæŽ»æ§çãçšããŠïŒã åç23.77ïœïŒ58.27ïŒ ïŒ åŸãããååç©ã¯ãå®æœäŸïŒã«ããåŸãããã
ã®ã«å¯Ÿå¿ããŠããã äžèšæ¹æ³ã«ãããäŸãã°ã次衚ã«èšèŒã®åŒ
ïŒïŒã®ååç©ãåŸãããšãã§ããã
ãè¡šã
å®æœäŸ ïŒ
ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒ
âããããã³ïŒïŒïŒR1ïŒïŒšãR2ïŒCH3ãR2ïŒ
R3ïŒãšãã«ïŒ ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1 20.0ïœïŒ5.24ïœã¢ã«ïŒã飜å
é žæ§çé žãããªãŠã 溶液20mlãšå¡©åã¡ãã¬ã³20ml
ãšã®éã«åé ãããææ©çžãåé¢ãã也ç¥ããæ¿
çž®ããããæ²¹ç¶æ®åã0.01ïœããŒã«åã³185â
ïŒç©ºæ°æµŽæž©åºŠïŒã§ç管ç¶èžæºåšã§èžæºããã åçïŒç¡è²æ²¹ç¶1.45ïœïŒ80ïŒ ïŒ å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãžãšããã«ã¢ãããšããã·ïŒâ
ïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«â
ïŒâããããã³ ïŒâã¯ãã«âïŒâãžã¡ãã«ã¢ãããšã¿ã³HC1
34.5ïœïŒ0.24ã¢ã«ïŒããæ°Ž250mlåã³çé žãžã¡ã
ã«ïŒDECïŒ150mläžã«Na2CO3 108ïœïŒïŒã¢ã«ïŒ
ã溶ããã飜åNa2CO3溶液ãš30åéæ¹æããã
ãã®ã¢ãã³æº¶æ¶²ãåŸæããŠã®ã¡ããªãïŒåçé žãž
ãšãã«90mlãš10åéæ¹æããäžç·ã«ããã¢ãã³æº¶
液ãç¡æ°Žã®ç¡«é žãããªãŠã åã³çé žãããªãŠã äž
ã§ä¹Ÿç¥ãããã 也ç¥ããã¢ãã³æº¶æ¶²ããããªãŠã ããšãã©ãŒã
ïŒããšããŒã«ãã¡ã¿ããŒã«æ§Naâã¡ãã¬ãŒã溶液
ã®åœéäžã«æº¶ãããééãäžå®ã«ãªããŸã§æ¿çž®ã
ãŠè£œé ããïŒ8.1ïœïŒ0.03ã¢ã«ïŒã«æ·»å ãã45å
éæ¹æããæ°Žãé®æããªããïŒKOH也ç¥ç®¡ïŒ90
âã«å ç±ããããã®æº¶æ¶²ãå·åŽããã®ã«ããã®å
å¿æ··åç©ããæåºå¡©ãé€å»ããããã«ãã¬ã©ã¹ã
ãªãããçµãŠåžåŒæ¿Ÿéãã溶液ãç空äžã§æ¿çž®ã
ããã æ²¹ç¶ã®æ®åããå¡©åã¡ãã¬ã³100mläžã«å ¥ãã
0.5n NaOHãããã20mlã§ïŒåãæ°Ž10mlã§ïŒå
æœåºãããäžç·ã«ããCH2CI2âçžã匷ã
4nHC120mlåã³æ°ŽïŒmlãšå ±ã«ïŒåæ¯ããæ°Žå±€ã
å¡©åã¡ãã¬ã³ïŒmlã§æ¯ãæ»ããäžç·ã«ããŠå¡©åã¡
ãã¬ã³çžãç¡æ°ŽNa2SO4äžã§ç¡æ°Žã«ä¹Ÿç¥ãããæ¿
çž®ãããã ãã®æ²¹ç¶ç²è£œçæç©ïŒ13.2ïœïŒãã¢ã»ãã³çŽ
500mläžã掻æ§çã§åŠçãããïŒâïŒâïŒïŒâãž
ãšãã«ã¢ãããšããã·ïŒâïŒâã¡ãã«âïŒâããš
ãã«ïŒœâïŒâããšãã«âïŒâããããã³âHC1
7.85ïœïŒããšããŒã«ã«å¯ŸããŠ73ïŒ ïŒãåŸãããã
èç¹ 106â108âïŒã¢ã»ãã³ïŒãDCïŒããªã°ã©ã
SIL ïŒUV254 溶åºå€ ãã«ãªãŒã«ïŒæ¿ã¢ã³ã¢ãã¢ïŒïŒïŒïŒïŒ
0.3 æçµç®çç© å¯èŠ UV Rf çŽ0.75ã¢ãã³ J2
âèžæ° ããšããŒã« å¯èŠ UV 1nHC1äžã®ïŒïŒ FeCl3 å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãããªãžãã«ãšããã·ïŒâïŒâ
ã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1 äŸïŒã«èª¬æããããã«å®æœããäœãããã®éã
ïŒâïŒïŒâã¯ãã«ãšãã«ãããªãžã³ïŒïŒHC1 è
ç¹ 230â233âïŒå解ïŒïŒæè¯140â190âïŒïŒæç®
230â233âïŒF.H.ã¯ã©ã«ã±ãJ.Org.Chem.26ã
1126â32ïŒ1961ïŒïŒ15ïœïŒ0.082ã¢ã«ïŒããŸã
DEC100mlã次ãã§DEC30mlãããŠæ°Ž100mläžã®
Na2CO3 36ïœïŒ0.34ã¢ã«ïŒã䜿çšããã 也ç¥åŸããã®ã¢ãã³æº¶æ¶²ããããªãŠã ããšãã©
ãŒã2.7ïœïŒ0.01ã¢ã«ïŒãšå ±ã«ïŒæéãæ¹æããª
ãã湿æ°ãé®æããŠ90âã«å ç±ããã ãã®åå¿æ··åç©ããäŸïŒã«èª¬æããããã«åŠç
ãããšãïŒâïŒâïŒïŒâãããªãžãã«ãšããã·ïŒ
âïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«â
ïŒâããããã³âHC1ïŒèç¹93â95âïŒã¢ã»ã
ã³ïŒ3.25ïœïŒããšããŒã«ã«å¯Ÿã82ïŒ ïŒãåŸãã
ãã DCïŒããªã°ã©ã SIL ïŒUV 0.67 溶åºå€ ãã«ãªãŒã«ïŒãšã¿ããŒã«ïŒæ¿ã¢ã³ã¢ãã¢
ïŒïŒïŒïŒïŒ0.3 RF çŽ0.67 å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãããªãžãã«ãšããã·ïŒâïŒâ
ã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1 äŸïŒã«èª¬æããããã«å®æœãããã®éããã
ããïŒâïŒïŒâã¯ãã«ãšãã«ïŒãããªãžã³HC1
ïŒèç¹ 173â174âã125°以åŸäžéšæè¯ããå€ç§»
ããïŒæç®ã«ããã¯173.5â174âïŒïŒJ.Am.Chem.
Soc.70ïŒ1948ïŒã3098â3100ãJ.B.WrightïŒãã€ã«
ã¹ã¿ã€ã³20ïŒIVïŒ66ãïŒ13.6ïœïŒ0.08ã¢ã«ïŒãå ã
DEC100mlããããŠDEC30mlãæ°Ž100mläžã®
NaCO337.5ïœã®æº¶æ¶²ã䜿çšããã 也ç¥ããã¢ãã³æº¶æ¶²ãäžç·ã«ãããããªãŠã ã
ãšãã©ãŒã2.7ïœïŒ0.010ã¢ã«ïŒãšïŒæéãæ¹æã
ãªãã湿æ°ãé®æããŠ90âã«å ç±ããã ãã®åå¿æ··åç©ããäŸïŒã«èª¬æããããã«åŸåŠ
çãããšãïŒâïŒâïŒïŒâãããªãžã«ãšããã·ïŒ
âïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«â
ïŒâããããã³âHC1ïŒèç¹84â86âïŒã¢ã»ã
ã³ïŒ2.1ïœïŒããšããŒã«ã«å¯Ÿã55ïŒ ïŒãåŸãããã DCïŒããªã°ã©ã SIL ïŒUV 0.67 溶åºå€ ãã«ãªãŒã«ïŒãšã¿ããŒã«ïŒæ¿ã¢ã³ã¢ãã¢
ïŒïŒïŒïŒïŒ0.3 RF çŽ0.63 å®æœäŸ ïŒ ïŒâïŒâïŒïŒâã¢ã«ããªãã«ïŒâãšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒ
âããããã³âHC1 äŸïŒã«èª¬æããããã«å®æœãããã®éããã
ããïŒâïŒïŒâã¯ãã«ãšãã«ïŒâã¢ã«ããªã³HC1
ïŒèç¹184â185âã150â以åŸæè¯ãæç®ã«ããã°
178â180âè¥ããã¯ã182â182.5âïŒF.ã¬ãªãã«
ããH.ãã«ã³ïŒJ.Am.Chem.Soc.62ã1445ïŒ1940ïŒ
15ïœãçé žãšãã«10mläžã§ããã€æ°Ž250mläžã®ç
é žãããªãŠã 39ïœã䜿çšããã ãã®ä¹Ÿç¥ããã¢ãã³æº¶æ¶²ã湿æ°ãé®æããŠæ¹æ
ããªãããããªãŠã ããšãã©ãŒã2.7ïœïŒ0.01ã¢
ã«ïŒãšäžç·ã«ïŒæéã90âã«å ç±ããããã®æº¶æ¶²
ããæåºããå¡©ãé€å»ãããããã¬ã©ã¹ããªãã
ãéããŠåžåŒæ¿Ÿéããç空ã§æ¿çž®ããããæ²¹ç¶ã®
æ®åãå¡©åã¡ãã¬ã³150mläžã«å ¥ãã0.56nNaOH
ãããã20mlã§ïŒåæ¯ããæŽã«æ°Ž15mlã§ïŒåæ¯
ããæŽã«å¡©åã¡ãã¬ã³10mlã§ïŒåæ¯ããNa2SO4
äžã§ä¹Ÿç¥ããå¡©åã¡ãã¬ã³çžãããæ²¹ç¶çµæç©
3.3ïœãåŸãããããã®éé¢å¡©åºãç³æ²¹ãšãŒãã«
ïŒ40ïŒ60ïŒïŒãšãŒãã«ïŒããªãšãã¬ã³ã¢ãã³ïŒ
10ïŒïŒïŒïŒã§ååŠçããçªé žã²ã«ã«ã©ã ãä»ããŠ
粟補ããã å¡©åã¡ãã¬ã³ã§ã®æº¶åºãå¡©åã¡ãã¬ã³çžã®æ¿
çž®ã4nHC1ã§ã®æ¯åºã也ç¥æ¿çž®ã«ãããïŒâïŒ
âïŒïŒâã¢ã«ããªãã«ïŒâãšããã·ïŒâïŒâã¡ãã«
âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâãããã
ã³âHC1 1.5ïœïŒããšããŒã«ã«å¯Ÿãçè«å€ã®37.6
ïŒ ïŒãåŸããããèç¹ïŒã¢ã»ãã³âãžã€ãœããã
ãããŒã«ãšãŒãã«ïŒ113â115âãDOïŒRfïŒ0.65 æ¬çºæååç©ã®è¬åŠç©ã®è¬åŠçæ§è³ª 代衚çååç©ãšããŠïŒâïŒâïŒïŒâãžãšãã«ã¢
ãããšããã·ïŒâïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒ
âããšãã«âïŒâããããã³âHC1ãããã®æ
äžæŽèäœçšåã³åŸªç°ç³»ã«å¯Ÿããäœçšã«ã€ããŠèª¿æ»
ãããå¹æçãªäžå¿æã®å»¶é·ãæäžæŽèäœçšå¹æ
ãåºæºãšããåçž®åã«å¯Ÿããäœçšã埪ç°äœçšã«å¯Ÿ
ãããã©ã¡ãŒã¿ãšããã æ¯èŒç©è³ªãšããŠã¯ãæ®ã«ããããžã³åã³ããã«
ã€ã³ãNaâæ®æäœçšãæããå žåçæäžæŽèå€
ãšããŠçšããã æ¹ æ³ è©Šéšã¯çŽ250â500ïœã®äœéãæããã¢ã«ã¢ãã
ã®æåºå·Šå¿æ¿åã³å³å¿å®€ã®ä¹³é çãçšããŠè¡ã€
ããä¹³é çã§ã®å®éšã§ã¯åšå®æº¶æ¶²ã«ã¯ã«ãªãŠã ã
å€éã«å«æãããããŒã溶液ãå ãããæ©èœçãª
äžå¿æïŒRPïŒã®æž¬å®ã¯äºéã·ã¹ãã åºæ¿è奮
ïŒãŽãã¢ãŒ1975ïŒã«ãã€ãŠè¡ã€ãããã®éã3ms
ãªãæéãšïŒHzãªãåºæ¬æ¯åæ°ãæããã¬ãããš
ãã¯ã¹ã€ã³ãã«ã¹ïŒRechtecksimpulseïŒãçšã
ããæå¹RPã枬å®ããã«ã¯ãäºéåºæ¿ãå ããã
ãããŠãã®éãåºæ¬åºæ¿ã«ã¯ããã®æéçé 延ã
æ£ç¢ºã«å€æŽã§ããåã第ïŒã®åºæ¿ãç¶ãããïŒã€
ã®èæã®éã®ééã¯ã第ïŒã®åºæ¿ãå¿æ¿çã®åçž®
ã以ãŠå¿çããããŸã§ããã®æž¬å®éçšã§å¢å€§ãã
ãã åã ã®çšéã®äœçšã®æéççµéã远跡ãããã
ãç©è³ªã«ã€ããŠæå¹å¹æã«ãŒããçšæãããå¹æ
çãªäžå¿æã«å¯Ÿããäœçšã®å€ã«å¹æã®ããåçž®å
ã«å¯Ÿããäœçšãåæã«æž¬å®ããã ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³HC1ãã10ÎŒMã®æ¿åºŠã§å ãããããž
ã³åã³ãªã«ãã€ã³ã100ÎŒMã®æ¿åºŠã§çµç¹æµŽã«å
ãããä»å çã«ãªããç©è³ªæ·»å ãè¡ããªãå¯Ÿç §å®
éšãå¹³è¡ããŠå®æœãããéšåçãªéå±æ§åããä¹³
é çã§ã®å®éšããä»å çã«22mMã®ã«ãªãŠã ãå«
æããçµç¹æµŽäžã§è¡ã€ããããããããšã«ããã
ç·©æºãªNaâCaâ现管ïŒKanaã»lchenïŒã ãã§ãª
ããè¿ éãªNaâ现管ãäžæŽ»æ§åããããã®ã¢ã
ã«ã¯å宀ã§ãã¹ãããæäžæŽèå€ã®ãã¬ãããªèµ°
å¿çäœçšãæ£ç¢ºã«èª¿æ»ããã®ã«é©åœã§ããã çµ æ ãããžã³ïŒ100ÎŒMïŒã¯30å以å ã«RPã161ïŒ å»¶
é·ããããªãã«ã€ã³ã¯åãæ¿åºŠã§ãRPãå ãã«
63ïŒ ã ã延é·ããããå¿æ¿ã®åçž®åã¯ã60å以å
ã«ãªã«ãã€ã³ã¯æ倧83ïŒ ãŸã§äœäžãããã®ã«å¯Ÿã
ãŠããããžã³ã«ãããš23ïŒ ãŸã§äœäžãããã ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1ïŒ10ÎŒMïŒã¯ãå¿æ¿ã®RPã60å
é以å ã«128ïŒ å»¶é·ããåçž®åã¯ãã®éã89ïŒ ãŸ
ã§äœäžããã ãã§ãããããã¯ã察象æ¡ä»¶äžãå³
ã¡ç©è³ªæ·»å ã®ãªãæ¡ä»¶äžã§ã60å以å ã«èŠ³å¯ãã
ãåçž®åäœäžã«å¯Ÿå¿ãããïŒâïŒâïŒïŒâãžãšã
ã«ã¢ãããšããã·ïŒâïŒâã¡ãã«âïŒâããšãã«ïŒœ
âïŒâããšãã«âïŒâããããã³âHC1ã¯3ÎŒM
ãªãæ¿åºŠã§ããåçž®åã®åæäœäžãªãã«ã73ïŒ ã®
RPã®å»¶é·ã瀺ããã åçš®ç©è³ªã®Naâ现管ã®éå¡ã«å¯Ÿããäœçšã調
ã¹ããããéšåçã«è±å極ããä¹³é çã§ã¯ãïŒâ
ïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒâã¡ã
ã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâããã
ãã³âHC1ã¯ãNaâæ®ææ§ãšã¯ç¡é¢ä¿ã«äœçšã
ãããšã瀺ããŠããã æ¯æ§è©Šéš ååŠåã®è©Šéšã«é¢ããOECDâã¬ã€ãã©ã€ã³No.
471ïŒâGenetic ToxicologyïŒSolmonella
typhimuriumãRevetse Mutation Assayâ
March 1982ïŒåã³Good Laboratory Practice
RegulationsïŒGLPïŒã®ä»é²åã³ããã«äŸããµã«
ã¢ãã©ã»ããã€ã ãªãŠã çªç¶å€ç°çææ€å®
ïŒAMES TESTïŒã§ãæ¬çºæã®ååç©ïŒLG84â
ïŒâ10ïŒïŒ ãè©Šéšããã ãã®å®éšã¯ãèæ ªãµã«ã¢ãã©ã»ããã€ã ãªãŠã
TA98ãTA100ãTA1535åã³TA1538ãçšãã
AMESã«äŸãããã¬ãŒãã»ã€ã³ã³ãŒãã¬ãŒã·ãš
ã³ã»ã¢ãã»ã€ãºããšããŠå®æœãããåèæ ªã§ïŒå
ã®ç¬ç«ããå®éšãè¡ã€ããåå®éšã«ãããŠãæ£å
ã³è² ã®å¯Ÿè±¡ãšäžŠè¡ããŠã代è¬æŽ»æ§åã®ããã®ã©ã
ãèèé µçŽ è£œåïŒèèãã€ã¯ããœãŒã ïŒã®ååšå
ã³äžååšäžã«ãç©è³ªãïŒçš®ã®æ¿åºŠã§è©Šéšãããã
ã¹ãŠã®è©Šæã¯ïŒéã«è©ŠéšãããLG84âïŒâ10ã¯ã
ãã®è©Šéšã§äœ¿çšããããµã«ã¢ãã©ã»ããã€ã ãªãŠ
ã ã®èæ ªã«å¯ŸããŠçªç¶å€ç°çæäœçšã瀺ããªãã€
ãã çªç¶å€ç°çæè©Šéš ïŒ äœ¿çšãµã«ã¢ãã©ã»ããã€ã ãªãŠã èæ ªïŒ
TA98ãTA100ãTA1535ãTA15382ã ïŒ ç©è³ªã®æº¶è§£æ§åã³æ¯æ§ã«å¿ããŠããã®çªç¶å€
ç°çæè©Šéšã®ããã«æ¬¡ã®æ¿åºŠãéžæããïŒ50ã
17ãïŒãïŒåã³1.9ÎŒïœïŒãã¬ãŒãã åèšïŒåïŒïŒèåœãïŒåïŒã®å®éšãè¡ã€ããå
è©Šéšç©è³ªã®ïŒçš®ã®æ¿åºŠã®å®éšãã代è¬æŽ»æ§åã®ã
ãã®èèé µçŽ è£œåïŒèèãã€ã¯ããœãŒã ïŒã®ååš
åã³äžååšäžã§ãæ£åã³è² ã®å¯Ÿç §ãšæ¯èŒãããçª
ç¶å€ç°çææ°ãïŒå枬å®ããã çµ±èšçã«è©äŸ¡ããã ïŒ çµè« ã©ã®LG84âïŒâ10ã®ã©ã®å®éšåã³æ¿åºŠã§ãã
çžå¿ããè² ã®å¯Ÿç §ã®å€ã®ïŒå以äžã®çªç¶å€ç°ç
æã®æ°ã®çµ±èšçææå¢å ãèµ·ãããªãã€ãã æŽã«ã匱ãçªç¶å€ç°æŽ»æ§ã瀺ãæ£ã®æäžéäž
å¿é¢ä¿ã瀺ãå®éšçµæã¯èªããããªãã€ãã ãã®å®éšã®çµæã§ã代è¬æŽ»æ§åã«ã¯äœãã®åœ±é¿
ã瀺ããªãã€ããåŸã€ãŠãLGâ84âïŒâ10ã¯ã
ãµã«ã¢ãã©ã»ããã€ã ãªãŠã ã«å¯ŸããŠçªç¶å€ç°ç
æããªãã€ãã
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒ
âããããã³ïŒïŒïŒR1ïŒïŒšãR2ïŒCH3ãR2ïŒ
R3ïŒãšãã«ïŒ ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1 20.0ïœïŒ5.24ïœã¢ã«ïŒã飜å
é žæ§çé žãããªãŠã 溶液20mlãšå¡©åã¡ãã¬ã³20ml
ãšã®éã«åé ãããææ©çžãåé¢ãã也ç¥ããæ¿
çž®ããããæ²¹ç¶æ®åã0.01ïœããŒã«åã³185â
ïŒç©ºæ°æµŽæž©åºŠïŒã§ç管ç¶èžæºåšã§èžæºããã åçïŒç¡è²æ²¹ç¶1.45ïœïŒ80ïŒ ïŒ å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãžãšããã«ã¢ãããšããã·ïŒâ
ïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«â
ïŒâããããã³ ïŒâã¯ãã«âïŒâãžã¡ãã«ã¢ãããšã¿ã³HC1
34.5ïœïŒ0.24ã¢ã«ïŒããæ°Ž250mlåã³çé žãžã¡ã
ã«ïŒDECïŒ150mläžã«Na2CO3 108ïœïŒïŒã¢ã«ïŒ
ã溶ããã飜åNa2CO3溶液ãš30åéæ¹æããã
ãã®ã¢ãã³æº¶æ¶²ãåŸæããŠã®ã¡ããªãïŒåçé žãž
ãšãã«90mlãš10åéæ¹æããäžç·ã«ããã¢ãã³æº¶
液ãç¡æ°Žã®ç¡«é žãããªãŠã åã³çé žãããªãŠã äž
ã§ä¹Ÿç¥ãããã 也ç¥ããã¢ãã³æº¶æ¶²ããããªãŠã ããšãã©ãŒã
ïŒããšããŒã«ãã¡ã¿ããŒã«æ§Naâã¡ãã¬ãŒã溶液
ã®åœéäžã«æº¶ãããééãäžå®ã«ãªããŸã§æ¿çž®ã
ãŠè£œé ããïŒ8.1ïœïŒ0.03ã¢ã«ïŒã«æ·»å ãã45å
éæ¹æããæ°Žãé®æããªããïŒKOH也ç¥ç®¡ïŒ90
âã«å ç±ããããã®æº¶æ¶²ãå·åŽããã®ã«ããã®å
å¿æ··åç©ããæåºå¡©ãé€å»ããããã«ãã¬ã©ã¹ã
ãªãããçµãŠåžåŒæ¿Ÿéãã溶液ãç空äžã§æ¿çž®ã
ããã æ²¹ç¶ã®æ®åããå¡©åã¡ãã¬ã³100mläžã«å ¥ãã
0.5n NaOHãããã20mlã§ïŒåãæ°Ž10mlã§ïŒå
æœåºãããäžç·ã«ããCH2CI2âçžã匷ã
4nHC120mlåã³æ°ŽïŒmlãšå ±ã«ïŒåæ¯ããæ°Žå±€ã
å¡©åã¡ãã¬ã³ïŒmlã§æ¯ãæ»ããäžç·ã«ããŠå¡©åã¡
ãã¬ã³çžãç¡æ°ŽNa2SO4äžã§ç¡æ°Žã«ä¹Ÿç¥ãããæ¿
çž®ãããã ãã®æ²¹ç¶ç²è£œçæç©ïŒ13.2ïœïŒãã¢ã»ãã³çŽ
500mläžã掻æ§çã§åŠçãããïŒâïŒâïŒïŒâãž
ãšãã«ã¢ãããšããã·ïŒâïŒâã¡ãã«âïŒâããš
ãã«ïŒœâïŒâããšãã«âïŒâããããã³âHC1
7.85ïœïŒããšããŒã«ã«å¯ŸããŠ73ïŒ ïŒãåŸãããã
èç¹ 106â108âïŒã¢ã»ãã³ïŒãDCïŒããªã°ã©ã
SIL ïŒUV254 溶åºå€ ãã«ãªãŒã«ïŒæ¿ã¢ã³ã¢ãã¢ïŒïŒïŒïŒïŒ
0.3 æçµç®çç© å¯èŠ UV Rf çŽ0.75ã¢ãã³ J2
âèžæ° ããšããŒã« å¯èŠ UV 1nHC1äžã®ïŒïŒ FeCl3 å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãããªãžãã«ãšããã·ïŒâïŒâ
ã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1 äŸïŒã«èª¬æããããã«å®æœããäœãããã®éã
ïŒâïŒïŒâã¯ãã«ãšãã«ãããªãžã³ïŒïŒHC1 è
ç¹ 230â233âïŒå解ïŒïŒæè¯140â190âïŒïŒæç®
230â233âïŒF.H.ã¯ã©ã«ã±ãJ.Org.Chem.26ã
1126â32ïŒ1961ïŒïŒ15ïœïŒ0.082ã¢ã«ïŒããŸã
DEC100mlã次ãã§DEC30mlãããŠæ°Ž100mläžã®
Na2CO3 36ïœïŒ0.34ã¢ã«ïŒã䜿çšããã 也ç¥åŸããã®ã¢ãã³æº¶æ¶²ããããªãŠã ããšãã©
ãŒã2.7ïœïŒ0.01ã¢ã«ïŒãšå ±ã«ïŒæéãæ¹æããª
ãã湿æ°ãé®æããŠ90âã«å ç±ããã ãã®åå¿æ··åç©ããäŸïŒã«èª¬æããããã«åŠç
ãããšãïŒâïŒâïŒïŒâãããªãžãã«ãšããã·ïŒ
âïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«â
ïŒâããããã³âHC1ïŒèç¹93â95âïŒã¢ã»ã
ã³ïŒ3.25ïœïŒããšããŒã«ã«å¯Ÿã82ïŒ ïŒãåŸãã
ãã DCïŒããªã°ã©ã SIL ïŒUV 0.67 溶åºå€ ãã«ãªãŒã«ïŒãšã¿ããŒã«ïŒæ¿ã¢ã³ã¢ãã¢
ïŒïŒïŒïŒïŒ0.3 RF çŽ0.67 å®æœäŸ ïŒ ïŒâïŒâïŒïŒâãããªãžãã«ãšããã·ïŒâïŒâ
ã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1 äŸïŒã«èª¬æããããã«å®æœãããã®éããã
ããïŒâïŒïŒâã¯ãã«ãšãã«ïŒãããªãžã³HC1
ïŒèç¹ 173â174âã125°以åŸäžéšæè¯ããå€ç§»
ããïŒæç®ã«ããã¯173.5â174âïŒïŒJ.Am.Chem.
Soc.70ïŒ1948ïŒã3098â3100ãJ.B.WrightïŒãã€ã«
ã¹ã¿ã€ã³20ïŒIVïŒ66ãïŒ13.6ïœïŒ0.08ã¢ã«ïŒãå ã
DEC100mlããããŠDEC30mlãæ°Ž100mläžã®
NaCO337.5ïœã®æº¶æ¶²ã䜿çšããã 也ç¥ããã¢ãã³æº¶æ¶²ãäžç·ã«ãããããªãŠã ã
ãšãã©ãŒã2.7ïœïŒ0.010ã¢ã«ïŒãšïŒæéãæ¹æã
ãªãã湿æ°ãé®æããŠ90âã«å ç±ããã ãã®åå¿æ··åç©ããäŸïŒã«èª¬æããããã«åŸåŠ
çãããšãïŒâïŒâïŒïŒâãããªãžã«ãšããã·ïŒ
âïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«â
ïŒâããããã³âHC1ïŒèç¹84â86âïŒã¢ã»ã
ã³ïŒ2.1ïœïŒããšããŒã«ã«å¯Ÿã55ïŒ ïŒãåŸãããã DCïŒããªã°ã©ã SIL ïŒUV 0.67 溶åºå€ ãã«ãªãŒã«ïŒãšã¿ããŒã«ïŒæ¿ã¢ã³ã¢ãã¢
ïŒïŒïŒïŒïŒ0.3 RF çŽ0.63 å®æœäŸ ïŒ ïŒâïŒâïŒïŒâã¢ã«ããªãã«ïŒâãšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒ
âããããã³âHC1 äŸïŒã«èª¬æããããã«å®æœãããã®éããã
ããïŒâïŒïŒâã¯ãã«ãšãã«ïŒâã¢ã«ããªã³HC1
ïŒèç¹184â185âã150â以åŸæè¯ãæç®ã«ããã°
178â180âè¥ããã¯ã182â182.5âïŒF.ã¬ãªãã«
ããH.ãã«ã³ïŒJ.Am.Chem.Soc.62ã1445ïŒ1940ïŒ
15ïœãçé žãšãã«10mläžã§ããã€æ°Ž250mläžã®ç
é žãããªãŠã 39ïœã䜿çšããã ãã®ä¹Ÿç¥ããã¢ãã³æº¶æ¶²ã湿æ°ãé®æããŠæ¹æ
ããªãããããªãŠã ããšãã©ãŒã2.7ïœïŒ0.01ã¢
ã«ïŒãšäžç·ã«ïŒæéã90âã«å ç±ããããã®æº¶æ¶²
ããæåºããå¡©ãé€å»ãããããã¬ã©ã¹ããªãã
ãéããŠåžåŒæ¿Ÿéããç空ã§æ¿çž®ããããæ²¹ç¶ã®
æ®åãå¡©åã¡ãã¬ã³150mläžã«å ¥ãã0.56nNaOH
ãããã20mlã§ïŒåæ¯ããæŽã«æ°Ž15mlã§ïŒåæ¯
ããæŽã«å¡©åã¡ãã¬ã³10mlã§ïŒåæ¯ããNa2SO4
äžã§ä¹Ÿç¥ããå¡©åã¡ãã¬ã³çžãããæ²¹ç¶çµæç©
3.3ïœãåŸãããããã®éé¢å¡©åºãç³æ²¹ãšãŒãã«
ïŒ40ïŒ60ïŒïŒãšãŒãã«ïŒããªãšãã¬ã³ã¢ãã³ïŒ
10ïŒïŒïŒïŒã§ååŠçããçªé žã²ã«ã«ã©ã ãä»ããŠ
粟補ããã å¡©åã¡ãã¬ã³ã§ã®æº¶åºãå¡©åã¡ãã¬ã³çžã®æ¿
çž®ã4nHC1ã§ã®æ¯åºã也ç¥æ¿çž®ã«ãããïŒâïŒ
âïŒïŒâã¢ã«ããªãã«ïŒâãšããã·ïŒâïŒâã¡ãã«
âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâãããã
ã³âHC1 1.5ïœïŒããšããŒã«ã«å¯Ÿãçè«å€ã®37.6
ïŒ ïŒãåŸããããèç¹ïŒã¢ã»ãã³âãžã€ãœããã
ãããŒã«ãšãŒãã«ïŒ113â115âãDOïŒRfïŒ0.65 æ¬çºæååç©ã®è¬åŠç©ã®è¬åŠçæ§è³ª 代衚çååç©ãšããŠïŒâïŒâïŒïŒâãžãšãã«ã¢
ãããšããã·ïŒâïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒ
âããšãã«âïŒâããããã³âHC1ãããã®æ
äžæŽèäœçšåã³åŸªç°ç³»ã«å¯Ÿããäœçšã«ã€ããŠèª¿æ»
ãããå¹æçãªäžå¿æã®å»¶é·ãæäžæŽèäœçšå¹æ
ãåºæºãšããåçž®åã«å¯Ÿããäœçšã埪ç°äœçšã«å¯Ÿ
ãããã©ã¡ãŒã¿ãšããã æ¯èŒç©è³ªãšããŠã¯ãæ®ã«ããããžã³åã³ããã«
ã€ã³ãNaâæ®æäœçšãæããå žåçæäžæŽèå€
ãšããŠçšããã æ¹ æ³ è©Šéšã¯çŽ250â500ïœã®äœéãæããã¢ã«ã¢ãã
ã®æåºå·Šå¿æ¿åã³å³å¿å®€ã®ä¹³é çãçšããŠè¡ã€
ããä¹³é çã§ã®å®éšã§ã¯åšå®æº¶æ¶²ã«ã¯ã«ãªãŠã ã
å€éã«å«æãããããŒã溶液ãå ãããæ©èœçãª
äžå¿æïŒRPïŒã®æž¬å®ã¯äºéã·ã¹ãã åºæ¿è奮
ïŒãŽãã¢ãŒ1975ïŒã«ãã€ãŠè¡ã€ãããã®éã3ms
ãªãæéãšïŒHzãªãåºæ¬æ¯åæ°ãæããã¬ãããš
ãã¯ã¹ã€ã³ãã«ã¹ïŒRechtecksimpulseïŒãçšã
ããæå¹RPã枬å®ããã«ã¯ãäºéåºæ¿ãå ããã
ãããŠãã®éãåºæ¬åºæ¿ã«ã¯ããã®æéçé 延ã
æ£ç¢ºã«å€æŽã§ããåã第ïŒã®åºæ¿ãç¶ãããïŒã€
ã®èæã®éã®ééã¯ã第ïŒã®åºæ¿ãå¿æ¿çã®åçž®
ã以ãŠå¿çããããŸã§ããã®æž¬å®éçšã§å¢å€§ãã
ãã åã ã®çšéã®äœçšã®æéççµéã远跡ãããã
ãç©è³ªã«ã€ããŠæå¹å¹æã«ãŒããçšæãããå¹æ
çãªäžå¿æã«å¯Ÿããäœçšã®å€ã«å¹æã®ããåçž®å
ã«å¯Ÿããäœçšãåæã«æž¬å®ããã ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³HC1ãã10ÎŒMã®æ¿åºŠã§å ãããããž
ã³åã³ãªã«ãã€ã³ã100ÎŒMã®æ¿åºŠã§çµç¹æµŽã«å
ãããä»å çã«ãªããç©è³ªæ·»å ãè¡ããªãå¯Ÿç §å®
éšãå¹³è¡ããŠå®æœãããéšåçãªéå±æ§åããä¹³
é çã§ã®å®éšããä»å çã«22mMã®ã«ãªãŠã ãå«
æããçµç¹æµŽäžã§è¡ã€ããããããããšã«ããã
ç·©æºãªNaâCaâ现管ïŒKanaã»lchenïŒã ãã§ãª
ããè¿ éãªNaâ现管ãäžæŽ»æ§åããããã®ã¢ã
ã«ã¯å宀ã§ãã¹ãããæäžæŽèå€ã®ãã¬ãããªèµ°
å¿çäœçšãæ£ç¢ºã«èª¿æ»ããã®ã«é©åœã§ããã çµ æ ãããžã³ïŒ100ÎŒMïŒã¯30å以å ã«RPã161ïŒ å»¶
é·ããããªãã«ã€ã³ã¯åãæ¿åºŠã§ãRPãå ãã«
63ïŒ ã ã延é·ããããå¿æ¿ã®åçž®åã¯ã60å以å
ã«ãªã«ãã€ã³ã¯æ倧83ïŒ ãŸã§äœäžãããã®ã«å¯Ÿã
ãŠããããžã³ã«ãããš23ïŒ ãŸã§äœäžãããã ïŒâïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1ïŒ10ÎŒMïŒã¯ãå¿æ¿ã®RPã60å
é以å ã«128ïŒ å»¶é·ããåçž®åã¯ãã®éã89ïŒ ãŸ
ã§äœäžããã ãã§ãããããã¯ã察象æ¡ä»¶äžãå³
ã¡ç©è³ªæ·»å ã®ãªãæ¡ä»¶äžã§ã60å以å ã«èŠ³å¯ãã
ãåçž®åäœäžã«å¯Ÿå¿ãããïŒâïŒâïŒïŒâãžãšã
ã«ã¢ãããšããã·ïŒâïŒâã¡ãã«âïŒâããšãã«ïŒœ
âïŒâããšãã«âïŒâããããã³âHC1ã¯3ÎŒM
ãªãæ¿åºŠã§ããåçž®åã®åæäœäžãªãã«ã73ïŒ ã®
RPã®å»¶é·ã瀺ããã åçš®ç©è³ªã®Naâ现管ã®éå¡ã«å¯Ÿããäœçšã調
ã¹ããããéšåçã«è±å極ããä¹³é çã§ã¯ãïŒâ
ïŒâïŒïŒâãžãšãã«ã¢ãããšããã·ïŒâïŒâã¡ã
ã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâããã
ãã³âHC1ã¯ãNaâæ®ææ§ãšã¯ç¡é¢ä¿ã«äœçšã
ãããšã瀺ããŠããã æ¯æ§è©Šéš ååŠåã®è©Šéšã«é¢ããOECDâã¬ã€ãã©ã€ã³No.
471ïŒâGenetic ToxicologyïŒSolmonella
typhimuriumãRevetse Mutation Assayâ
March 1982ïŒåã³Good Laboratory Practice
RegulationsïŒGLPïŒã®ä»é²åã³ããã«äŸããµã«
ã¢ãã©ã»ããã€ã ãªãŠã çªç¶å€ç°çææ€å®
ïŒAMES TESTïŒã§ãæ¬çºæã®ååç©ïŒLG84â
ïŒâ10ïŒïŒ ãè©Šéšããã ãã®å®éšã¯ãèæ ªãµã«ã¢ãã©ã»ããã€ã ãªãŠã
TA98ãTA100ãTA1535åã³TA1538ãçšãã
AMESã«äŸãããã¬ãŒãã»ã€ã³ã³ãŒãã¬ãŒã·ãš
ã³ã»ã¢ãã»ã€ãºããšããŠå®æœãããåèæ ªã§ïŒå
ã®ç¬ç«ããå®éšãè¡ã€ããåå®éšã«ãããŠãæ£å
ã³è² ã®å¯Ÿè±¡ãšäžŠè¡ããŠã代è¬æŽ»æ§åã®ããã®ã©ã
ãèèé µçŽ è£œåïŒèèãã€ã¯ããœãŒã ïŒã®ååšå
ã³äžååšäžã«ãç©è³ªãïŒçš®ã®æ¿åºŠã§è©Šéšãããã
ã¹ãŠã®è©Šæã¯ïŒéã«è©ŠéšãããLG84âïŒâ10ã¯ã
ãã®è©Šéšã§äœ¿çšããããµã«ã¢ãã©ã»ããã€ã ãªãŠ
ã ã®èæ ªã«å¯ŸããŠçªç¶å€ç°çæäœçšã瀺ããªãã€
ãã çªç¶å€ç°çæè©Šéš ïŒ äœ¿çšãµã«ã¢ãã©ã»ããã€ã ãªãŠã èæ ªïŒ
TA98ãTA100ãTA1535ãTA15382ã ïŒ ç©è³ªã®æº¶è§£æ§åã³æ¯æ§ã«å¿ããŠããã®çªç¶å€
ç°çæè©Šéšã®ããã«æ¬¡ã®æ¿åºŠãéžæããïŒ50ã
17ãïŒãïŒåã³1.9ÎŒïœïŒãã¬ãŒãã åèšïŒåïŒïŒèåœãïŒåïŒã®å®éšãè¡ã€ããå
è©Šéšç©è³ªã®ïŒçš®ã®æ¿åºŠã®å®éšãã代è¬æŽ»æ§åã®ã
ãã®èèé µçŽ è£œåïŒèèãã€ã¯ããœãŒã ïŒã®ååš
åã³äžååšäžã§ãæ£åã³è² ã®å¯Ÿç §ãšæ¯èŒãããçª
ç¶å€ç°çææ°ãïŒå枬å®ããã çµ±èšçã«è©äŸ¡ããã ïŒ çµè« ã©ã®LG84âïŒâ10ã®ã©ã®å®éšåã³æ¿åºŠã§ãã
çžå¿ããè² ã®å¯Ÿç §ã®å€ã®ïŒå以äžã®çªç¶å€ç°ç
æã®æ°ã®çµ±èšçææå¢å ãèµ·ãããªãã€ãã æŽã«ã匱ãçªç¶å€ç°æŽ»æ§ã瀺ãæ£ã®æäžéäž
å¿é¢ä¿ã瀺ãå®éšçµæã¯èªããããªãã€ãã ãã®å®éšã®çµæã§ã代è¬æŽ»æ§åã«ã¯äœãã®åœ±é¿
ã瀺ããªãã€ããåŸã€ãŠãLGâ84âïŒâ10ã¯ã
ãµã«ã¢ãã©ã»ããã€ã ãªãŠã ã«å¯ŸããŠçªç¶å€ç°ç
æããªãã€ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ åŒäžããšR1ãšã¯ãæ°ŽçŽ åã¯ã¡ãã«ãæå³ãã
R2ãšR3ãšã¯åäžåã¯ç°ãªã€ãŠããŠãããããã
ãïŒåãŸã§ã®ïŒ£âååãæããã¢ã«ãã«ãã·ã¯ã
ã¢ã«ãã«ãã¢ã«ã±ãã«åã¯ã¢ã«ããã«ã§ãããå
R2ãšR3ãšã¯ãããçµåããŠããçªçŽ ååãšå ±ã«ã
ïŒâïŒåã®ççŽ ååãæãã飜åã®ç°åã¯ãé žçŽ
åã¯çªçŽ ååããããååãšããŠç°äžã«æããŠã
ãŠãã飜åãããç°ã圢æãããã®å±€ãä»å çãª
çªçŽ ã¯ïŒâïŒåã®ççŽ ååãæããã¢ã«ãã«åºã§
眮æãããŠããŠããã§ç€ºãããïŒâïŒâïŒïŒâ
ãžã¢ã«ãã«ã¢ãããšããã·ïŒâïŒâããšãã«ïŒœâïŒ
âããšãã«âïŒâããããã³é¡åã³ãããã®é žä»
å å¡©ã ïŒ ïŒâïŒâïŒïŒâãžã«ã¢ãããšããã·ïŒâïŒâ
ã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâã
ãããã³âHC1ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®ååç©ã ïŒ ïŒâïŒâïŒïŒâãžã¡ãã«ã¢ãããšããã·ïŒâ
ïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒ
âããããã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ã ïŒ ïŒâïŒâïŒïŒâãããªãžãã«ãšããã·ïŒâïŒ
âã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâ
ããããã³âHC1ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®ååç©ã ïŒ ïŒâïŒâïŒïŒâãããªãžã«ãšããã·ïŒâïŒâ
ã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«âïŒâã
ãããã³âHC1ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®ååç©ã ïŒ ïŒâïŒâïŒïŒâïŒïŒâã¢ã«ããªãã«ïŒâãšãã
ã·ïŒâïŒâã¡ãã«âïŒâããšãã«ïŒœâïŒâããšãã«
âïŒâããããã³âHCIã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ååç©ã ïŒ äžè¬åŒ åŒäžããšR1ãšã¯ãæ°ŽçŽ åã¯ã¡ãã«ãæå³ãã
R2ãšR3ãšã¯åäžåã¯ç°ãªã€ãŠããŠãããããã
ãïŒåãŸã§ã®ïŒ£âååãæããã¢ã«ãã«ãã·ã¯ã
ã¢ã«ãã«ãã¢ã«ã±ãã«åã¯ã¢ã«ããã«ã§ãããå
R2ãšR3ãšã¯ãããçµåããŠããçªçŽ ååãšå ±ã«ã
ïŒâïŒåã®ççŽ ååãæãã飜åã®ç°åã¯ãé žçŽ
åã¯çªçŽ ååããããååãšããŠç°äžã«æããŠã
ãŠãã飜åãããç°ã圢æãããã®éãä»å çãª
çªçŽ ã¯ïŒâïŒåã®ççŽ ååãæããã¢ã«ãã«åºã§
眮æãããŠããŠããã§ç€ºãããïŒâïŒâïŒïŒâ
ãžã¢ã«ãã«ã¢ãããšããã·ïŒâïŒâããšãã«ïŒœâïŒ
âããšãã«âïŒâããããã³é¡åã³ãããã®é žä»
å å¡©ã補é ãããããäžè¬åŒïŒ åŒäžïŒ²ãšR1ã¯äžèšã®æå³ãæããKat+ã¯ã¢ã«
ã«ãªéå±åã¯ç¬¬ïŒçŽã¢ã³ã¢ããŠã ãæå³ããã§
瀺ãããååç©ãšåŒ åŒäžHalã¯ã¯ãã«ããšãŒãåã¯ããã ãæå³
ããR2ãšR3ãšã¯äžèšã®æå³ãæããã§ç€ºãã
ãååç©ãšãåå¿æ§ã®ãªã溶å€äžã§åå¿ãããã
ãããŠåŸãããåŒïŒïŒã®å¡©åºããå Žåã«ããã
ã®å¡©ä»å å¡©ã«å€æããããšãç¹åŸŽãšãããïŒâ
ïŒâïŒïŒâãžã¢ã«ãã«ã¢ãããšããã·ïŒâïŒâã
ãšãã«ïŒœâïŒâããšãã«âïŒâããããã³åã³ã
ããã®è®ä»å å¡©ã®è£œé æ¹æ³ã ïŒ äžè¬åŒ åŒäžããšR1ãšã¯ãæ°ŽçŽ åã¯ã¡ãã«ãæå³ãã
R2ãšR3ãšã¯åäžåã¯ç°ãªã€ãŠããŠãããããã
ãïŒåãŸã§ã®ïŒ£âååãæããã¢ã«ãã«ãã·ã¯ã
ã¢ã«ãã«ãã¢ã«ã±ãã«åã¯ã¢ã«ããã«ã§ãããå
R2ãšR3ãšã¯ãããçµåããŠããçªçŽ ååãšå ±ã«ã
ïŒâïŒåã®ççŽ ååãæãã飜åã®ç°åã¯ãé žçŽ
åã¯çªçŽ ååããããååãšããŠç°äžã«æããŠã
ãŠãã飜åãããç°ã圢æãããã®éãä»å çãª
çªçŽ ã¯ïŒâïŒåã®ççŽ ååãæããã¢ã«ãã«åºã§
眮æãããŠããŠããã§ç€ºãããïŒâïŒâïŒïŒâ
ãžã¢ã«ãã«ã¢ãããšããã·ïŒâïŒâããšãã«ïŒœâïŒ
âããšãã«âïŒâããããã³é¡åã³ãããã®é žä»
å å¡©ããè¬åŠçã«èªå®¹ã§ããæ äœã䞊ã³ã«ãå Žå
ã«ãããã®ä»ã®æå¹ç©è³ªãšæ··åããŠå«æããããš
ãç¹åŸŽãšããæäžæŽèå€ã
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT287086 | 1986-10-29 | ||
AT2870/86 | 1986-10-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63112577A JPS63112577A (ja) | 1988-05-17 |
JPH0442385B2 true JPH0442385B2 (ja) | 1992-07-13 |
Family
ID=3541613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62065527A Granted JPS63112577A (ja) | 1986-10-29 | 1987-03-19 | ïŒâïŒâïŒïŒâãžã¢ã«ãã«ã¢ãããšããã·ïŒâïŒâããšãã«ïŒœâïŒâãã§ãã«âïŒâããããã³åã³ãããã®é žä»å å¡©ïŒãããã®è£œæ³åã³ããããå«æããæäžæŽèå€ |
Country Status (10)
Country | Link |
---|---|
US (1) | US4814330A (ja) |
EP (1) | EP0266336B1 (ja) |
JP (1) | JPS63112577A (ja) |
AT (1) | ATE63550T1 (ja) |
CA (1) | CA1298832C (ja) |
DE (1) | DE3770117D1 (ja) |
DK (1) | DK164318C (ja) |
ES (1) | ES2036600T3 (ja) |
FI (1) | FI88502C (ja) |
NO (1) | NO170630C (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT391316B (de) * | 1988-09-15 | 1990-09-25 | Ebewe Arzneimittel | Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
AT392967B (de) * | 1989-01-24 | 1991-07-25 | Laevosan Gmbh & Co Kg | Neue 1-(3-(2-hydroxy-3-alkylaminopropoxy)-2- thienyl)-3-phenyl-1-propanone und verfahren zu deren herstellung |
WO1996008373A1 (en) * | 1994-09-16 | 1996-03-21 | Videojet Systems International, Inc. | Continuous ink jet printing system for use with hot-melt inks |
SE9602286D0 (sv) * | 1996-06-10 | 1996-06-10 | Astra Ab | New compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT369739B (de) * | 1980-11-28 | 1983-01-25 | Laevosan Gmbh & Co Kg | Verfahren zur herstellung neuer 1-(3-(2-hydroxy-3alkylaminopropoxy)-2-thienyl)-3-phenyl-1- propanone und ihrer saeureadditionssalze |
DE3316155A1 (de) * | 1983-05-03 | 1984-11-08 | Helopharm W. Petrik & Co Kg, 1000 Berlin | 2-(2'hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-1-thienylpropiophenon, seine saeureadditionssalze, verfahren zu seiner herstellung und arzneimittel |
-
1987
- 1987-03-03 DE DE8787890040T patent/DE3770117D1/de not_active Expired - Lifetime
- 1987-03-03 EP EP87890040A patent/EP0266336B1/de not_active Expired - Lifetime
- 1987-03-03 ES ES198787890040T patent/ES2036600T3/es not_active Expired - Lifetime
- 1987-03-03 AT AT87890040T patent/ATE63550T1/de not_active IP Right Cessation
- 1987-03-11 US US07/024,798 patent/US4814330A/en not_active Expired - Fee Related
- 1987-03-12 CA CA000531928A patent/CA1298832C/en not_active Expired - Lifetime
- 1987-03-19 JP JP62065527A patent/JPS63112577A/ja active Granted
- 1987-03-19 DK DK141187A patent/DK164318C/da not_active IP Right Cessation
- 1987-03-19 NO NO871140A patent/NO170630C/no unknown
- 1987-03-20 FI FI871253A patent/FI88502C/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK141187A (da) | 1988-04-30 |
FI871253A0 (fi) | 1987-03-20 |
FI88502C (fi) | 1993-05-25 |
EP0266336B1 (de) | 1991-05-15 |
DE3770117D1 (de) | 1991-06-20 |
DK164318C (da) | 1992-11-02 |
CA1298832C (en) | 1992-04-14 |
NO871140D0 (no) | 1987-03-19 |
EP0266336A1 (de) | 1988-05-04 |
DK164318B (da) | 1992-06-09 |
JPS63112577A (ja) | 1988-05-17 |
FI88502B (fi) | 1993-02-15 |
US4814330A (en) | 1989-03-21 |
DK141187D0 (da) | 1987-03-19 |
ATE63550T1 (de) | 1991-06-15 |
NO871140L (no) | 1988-05-02 |
FI871253A (fi) | 1988-04-30 |
ES2036600T3 (es) | 1993-06-01 |
NO170630B (no) | 1992-08-03 |
NO170630C (no) | 1992-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6192016B2 (ja) | ããããã·ã«äŸäžäœãšããŠã®æ°èŠããããœååç©ããã³ãã®äœ¿çšæ¹æ³ | |
KR101813551B1 (ko) | ì ê·ì ì늬ì ìŒë¡ ì ì©í ëížë¡ì€ ëëë¡ì ïœ-íëë¡ì€ì í°ì믞ë ì ë첎 | |
US8119627B2 (en) | Heterocyclic compounds as inhibitors of 17beta-HSD3 | |
EP2509941B1 (en) | N-acylated hydroxylamine derivatives and o-acylated hydroxylamine derivatives | |
JP5548869B2 (ja) | æ°èŠã§ççåŠçã«æçšãªããããã·ã«äŸäžäœãšããŠã®ïœâããããã·ã«ã¹ã«ãã³ã¢ããèªå°äœ | |
EP1718621A2 (en) | Nitroxyl progenitor compounds and methods of use | |
JP2009530303A5 (ja) | ||
EP2865664B1 (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
EP2496230B1 (en) | Ire-1 alpha inhibitors | |
EP0484378B1 (en) | Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides | |
JPS6216942B2 (ja) | ||
JPH0442385B2 (ja) | ||
JPH02178280A (ja) | æ°èŠã®ïŒâã¢ã¶ãã·ã¯ãã¢ã«ã«ã³èªå°äœããããã®è£œé æ¹æ³åã³ãããã®è¬å€ãšããŠã®äœ¿çš | |
SK2722002A3 (en) | Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia | |
JP5677855B2 (ja) | æ°èŠæææèªå°äœããããã®è£œé æ¹æ³ãããããå«æããå»è¬çµæç©ãåã³æ²»çã«ããããã®èªå°äœã®äœ¿çš | |
EP0626959A1 (en) | Benzopyran class iii antiarrhythmic agents | |
JP2002537228A (ja) | 眮æïŒâïŒããºãªãžã³âïŒâã€ã«ïŒâïŒâã¢ãªãŒã«ã€ãœããªãŠã¬ã¢ããããã®è£œé æ³ããã³ãããã®æ²»ççšé | |
JPH0320384B2 (ja) | ||
JPS6229428B2 (ja) | ||
KR20020019923A (ko) | 벀조ìŒíŒëŠ¬ë€ì§ | |
EP0182271B1 (de) | Neue Nb-quartÀre Dibromderivate von Ajmalin, Isoajmalin, Sandwicin und Isosandwicin sowie diese Derivate enthaltende pharmazeutische Zubereitungen und Zwischenprodukte und Verfahren zu ihrer Herstellung | |
US2668856A (en) | P-methoxy benzhydryl ethers | |
JPS62178585A (ja) | ïŒâãïŒâïŒïŒâããããã·âïŒâã¢ã«ãã«ã¢ããããããã·ïŒâïŒâããšãã«ãâïŒâããšãã«âïŒâããããã³åã³ãããã®é žä»å 塩䞊ã³ã«ãããã®è£œé æ³åã³ããããå«ãè¬åŠççµæç© | |
KR800001545B1 (ko) | íŒë¡€ëŠ¬ë ì ë첎ì ì ì¡°ë°©ë² | |
KR850000431B1 (ko) | íŒë¡€ ì ë첎ì ì ì¡°ë°©ë² |